| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4003077 | American Journal of Ophthalmology | 2012 | 8 Pages |
Abstract
AMD progression seems to be associated with increased annual Medicare expenditures. Findings suggest that halting or slowing disease progression using proven treatment such as Age-Related Eye Disease Study-endorsed vitamins or novel technologies could have a substantial positive impact by lowering public health expenditures.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Jordana K. Schmier, David W. Covert, Edmund C. Lau,